[Efficacy and safety analysis of avapritinib in children with RUNX1::RUNX1T1 positive-acute myeloid leukemia with KIT mutations]
{{output}}
Objective: To evaluate the efficacy and safety of avapritinib in children with RUNX1::RUNX1T1-positive acute myeloid leukemia (AML) with KIT mutations. Methods: Clinical data on children with RUNX1::RUNX1T1-positive AML with KIT mutations who received avapriti... ...
